NSW Health advice

  • Everyone 12 years and over in NSW is eligble to get vaccinted.
  • The Pfizer (Comirnaty) and Moderna (Spikevax) vaccines are approved for use in people aged 12 years and over. The AstraZeneca (Vaxzevria) vaccine is approved for use in people aged 18 years and over.
  • The COVID-19 vaccines are available through NSW Health clinics, participating general practices and pharmacies and Aboriginal Medical Services, with fully informed consent.
  • The Pfizer (Comirnaty) and Moderna (Spikevax) vaccines are the preferred COVID-19 vaccine for pregnant women at any stage of pregnancy.
  • People of any age who have received their first dose of COVID-19 AstraZeneca vaccine should be offered the second dose of AstraZeneca vaccine, unless they experienced a serious adverse event following the first dose.
  • People can receive the second dose of AstraZeneca vaccine at 4 to 8 weeks to achieve better protection more quickly.

For detailed information, read the Australian Technical Advisory Group on Immunisation (ATAGI) clinical guidance on COVID-19 vaccine in Australia in 2021.

Vaccination clinics

These are supporting documents for the NSW Health Policy Directive PD2021_048 - Standard operating procedure for administration of COVID-19 vaccines in NSW vaccination clinics (updated 21 December 2021).

Authorities and licences

Contraindication form

The form below should only be completed by medical practitioners if:

  • A person has a medical contraindication to receiving any available COVID-19 vaccine; or
  • A person has a medical contraindication to receiving one brand of COVID-19 vaccine and requires evidence for receiving an alternative brand; or
  • A person has a temporary medical contraindication to any COVID-19 vaccine (note, this exemption is only available for a maximum of 6 months at which time the form needs to be recompleted if the condition persists). Examples include:
    • Significant immunocompromise
    • Recent history of SARS-CoV-2 infection (PCR confirmed)
    • Acute medical illness.

If a person has had COVID-19 and has fully recovered, there is no need to delay vaccination. The medical clearance notice provided to the person can be used as a temporary exemption from vaccination for 6 weeks only.

Medical practitioners should consult the latest ATAGI clinical guidance for further information on medical contraindications:

For use by medical practitioners:

Adverse events

Joint statement from ATAGI and THANZ on Thrombosis with Thrombocytopenia Syndrome (TTS) and the use of COVID-19 Vaccine AstraZeneca

Serious Adverse Events Following Immunisation (AEFI) are notifiable conditions in NSW. Healthcare providers are required to report any serious AEFI to NSW Health and the Therapeutic Goods Administration.

AEFI reporting

AEFI management

COVID-19 vaccine safety surveillance

COVID-19 vaccination clinic: Job action sheets

Training resources

Training modules are available for clinical staff including:

A multi-dose vial training module will be made available soon.

More information

Current as at: Thursday 23 December 2021
Contact page owner: Health Protection NSW